Advertisement
Australia markets closed
  • ALL ORDS

    8,039.90
    +27.80 (+0.35%)
     
  • ASX 200

    7,796.00
    +26.60 (+0.34%)
     
  • AUD/USD

    0.6649
    -0.0010 (-0.15%)
     
  • OIL

    81.51
    +0.22 (+0.27%)
     
  • GOLD

    2,346.90
    -22.10 (-0.93%)
     
  • Bitcoin AUD

    96,157.51
    -1,357.49 (-1.39%)
     
  • CMC Crypto 200

    1,334.75
    -25.58 (-1.88%)
     
  • AUD/EUR

    0.6216
    -0.0001 (-0.02%)
     
  • AUD/NZD

    1.0862
    -0.0011 (-0.10%)
     
  • NZX 50

    11,682.39
    -89.42 (-0.76%)
     
  • NASDAQ

    19,731.50
    -20.79 (-0.11%)
     
  • FTSE

    8,237.50
    -34.96 (-0.42%)
     
  • Dow Jones

    39,213.55
    +78.79 (+0.20%)
     
  • DAX

    18,140.79
    -113.39 (-0.62%)
     
  • Hang Seng

    18,028.52
    -306.80 (-1.67%)
     
  • NIKKEI 225

    38,596.47
    -36.55 (-0.09%)
     

Could This Major Development Be a Game Changer for Altria Stock?

Could This Major Development Be a Game Changer for Altria Stock?

Maybe the third time will be the charm for Altria Group (NYSE: MO), which is taking the field again in electronic cigarettes after entering into a joint venture with Japan Tobacco (OTC: JAPAF) to co-market new reduced-risk products. After its ownership stake in Juul Labs went up in smoke and its partnership with Philip Morris International (NYSE: PM) was blocked by patent violations, this new deal could represent Altria's best shot at becoming a player again in the space. Altria and Japan Tobacco are forming Horizon Innovations, a joint venture 75% owned by the U.S. cigarette maker and 25% owned by its Japanese counterpart, that will oversee U.S. commercialization of any products either company develops.